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acute therapeutic relevance. The ultrasound studies were 
performed at the site of the emergency or in the ambulance 
during patient transport to the admitting hospital. Relevant 
timelines, such as the time from the stroke alarm to patient 
arrival at the hospital and the duration of the TCCS, were doc-
umented, and positive and negative predictive values for the 
diagnosis of major MCA occlusion were assessed.  Results: A 
total of 113 patients were enrolled in the study. MCA occlu-
sion was diagnosed in 10 patients. In 9 of these 10 patients, 
MCA occlusion could be visualized using contrast-enhanced 
or non-contrast-enhanced TCCS during patient transport 
and was later confirmed using computed tomography or 
magnetic resonance angiography. One MCA occlusion was 
missed by TCCS and 1 atypical hemorrhage was misdiag-
nosed. Overall, the sensitivity of a ‘field diagnosis’ of MCA 
occlusion was 90% [95% confidence interval (CI) 55.5–
99.75%] and the specificity was 98% (95% CI 92.89–99.97%). 
The positive predictive value was 90% (95% CI 55.5–99.75%) 
and the negative predictive value was 98% (95% CI 92.89–
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 Abstract 
 Background and Purpose: The primary aim of this study was 
to investigate the diagnostic accuracy and time frames
for neurological and transcranial color-coded sonography 
(TCCS) assessments in a prehospital ‘911’ emergency stroke 
situation by using portable duplex ultrasound devices to vi-
sualize the bilateral middle cerebral arteries (MCAs).  Meth-
ods: This study was conducted between May 2010 and Janu-
ary 2011. Patients who had sustained strokes in the city of 
Regensburg and the surrounding area in Bavaria, Germany, 
were enrolled in the study. After a ‘911 stroke code’ call had 
been dispatched, stroke neurologists with expertise in ultra-
sonography rendezvoused with the paramedic team at the 
site of the emergency. After a brief neurological assessment 
had been completed, the patients underwent TCCS with op-
tional administration of an ultrasound contrast agent in cas-
es of insufficient temporal bone windows or if the agent had 
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99.97%). The mean time (standard deviation) from ambu-
lance dispatch to arrival at the patient was 12.3 min (7.09); the 
mean time for the TCCS examination was 5.6 min (2.2); and 
the overall mean transport time to the hospital was 53 min 
(18).  Conclusion: Prehospital diagnosis of MCA occlusion in 
stroke patients is feasible using portable duplex ultrasonog-
raphy with or without administration of a microbubble con-
trast agent. Prehospital neurological as well as transcranial 
vascular assessments during patient transport can be per-
formed by a trained neurologist with high sensitivity and 
specificity, perhaps opening an additional therapeutic win-
dow for sonothrombolysis or neuroprotective strategies. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 The role of transcranial ultrasonography as a diagnos-
tic tool is expanding to accommodate a new function as a 
therapeutic tool in the treatment of acute ischemic stroke. 
Despite the availability of treatment with intravenous re-
combinant tissue plasminogen activator (rtPA), now ex-
panded to a time window of 4.5 h  after stroke, only a mi-
nority of patients receive and benefit from this therapy, 
leaving stroke the leading cause of disability in industrial-
ized countries. Sonothrombolysis has the potential of 
 becoming an interesting alternative to intravenous and 
intra-arterial rtPA treatment in addition to a growing 
number of efficient thrombectomy devices in the re-
establishment of cerebral blood flow following stroke  [1–
4] . Clinical data on sonothrombolysis in patients with 
acute ischemic stroke differ in efficacy and safety – the 
latter often due to the experimental transmission power, 
waveform and frequencies that are employed. Successful 
trials of sonothrombolysis, such as the ‘clotbust’ study by 
Alexandrov et al.  [5] , demonstrated that continuous in-
sonation using diagnostic transcranial Doppler sonogra-
phy (TCD) significantly decreased the thrombus burden 
and the time to recanalization whereas the ‘trumbi’ trial 
resulted in a high number of symptomatic intracerebral 
hemorrhages (ICHs); however, sonothrombolysis was of-
ten performed in combination with intravenous rtPA 
treatment  [5–7] . Despite the overall excitement about ul-
trasound-enhanced thrombolysis in stroke, all current 
therapeutic approaches require the patient’s hospitaliza-
tion. Time, however, is the most limiting factor for all 
stroke treatment options and the most significant prehos-
pital delay still occurs before the emergency dispatch cen-
ter is informed, and educational campaigns often fail to 
increase stroke awareness  [8, 9] . Given a neuron death rate 
of 1.9 million per minute, a treatment option that could 
be made available at the site of the emergency or during 
patient transport to the hospital could potentially lead to 
a paradigm shift in stroke treatment  [10] .
 Portable color-coded duplex ultrasound machines en-
able clinicians to perform prehospital sonothrombolysis 
much earlier than treatment with intravenous rtPA, 
which mandatorily requires neuroimaging with cerebral 
computed tomography (CT) or magnetic resonance im-
aging (MRI) to exclude the possibility of cerebral hemor-
rhage. In a preliminary study, we demonstrated the feasi-
bility of transcranial color-coded sonography (TCCS) in 
a nonselective, nonstroke patient series during patient 
transport in emergency helicopters and ambulances  [11] .
 In 2008, a joint program for prehospital stroke diag-
nosis and treatment was established between the Univer-
sity of California, San Diego (UCSD) in the USA, and the 
University of Regensburg in Germany. At the UCSD 
Brain Ultrasound Research Laboratory (under the direc-
tion of Thilo Hölscher, MD) sonothrombolysis research 
is currently being performed using diagnostic ultrasound 
and microbubbles; in Regensburg (under the direction of 
Felix Schlachetzki, MD, and Sandra Boy, MD) the clini-
cal, diagnostic part of the project is under way. After the 
feasibility of prehospital transcranial duplex ultrasonog-
raphy had been demonstrated during the initial phase of 
this project, the purpose of the current study became to 
test the sensitivity and specificity of the treatment in pa-
tients suffering acute stroke. In this study, only ‘code 
stroke’ patients were enrolled, and a combined neurolog-
ical and TCCS examination was performed either at the 
patient’s residence or during transport to the admitting 
stroke unit.
 The overall aim of this study was to perform prehos-
pital neurosonography to verify a neurological diagnosis 
of large intracranial vessel occlusion at the earliest pos-
sible time point. Specifically, we addressed the following 
points: feasibility of TCCS in prehospital diagnostics of 
acute stroke syndromes and determination of time frames 
for potential prehospital sonothrombolysis.
 Materials and Methods 
 Population and Study Protocol 
 The study protocol was approved by the local ethics committee 
at the University of Regensburg in accordance with the Declara-
tion of Helsinki and after review of clinical and safety data from 
the previous study. Patient enrollment took place during regular 
work hours (8 a.m.–4: 30 p.m.), Monday through Friday. Despite 
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received informed consent from the patient or the next available 
relative at the site of the emergency situation. Since the aim of the 
study was to show the feasibility of the procedure in emergency 
stroke situations, all patients with a clinical-neurological stroke 
diagnosis or stroke differential diagnosis were studied consecu-
tively, independent of the severity of the patient’s symptoms. A 
rendezvous protocol was used to treat the patient. After a 112 
stroke call was made (equivalent to a 911 call in the USA), the am-
bulance team (emergency physician and paramedic) and the 
stroke team [an experienced neurologist and a paramedic driver 
in a dedicated ‘stroke mobile’ (BMW, series 1)] rendezvoused at 
the site of the incident ( fig. 1 ). The protocol required, without ex-
ception, first aid and stabilization of the patient’s vital parame-
ters, even in cases in which the neurosonography team arrived 
before the emergency physician. Then a brief neurological exam-
ination was made, followed immediately by a TCCS assessment. 
Emergency physician with










 Fig. 1. Work flow of the rendezvous system, in which the emergency physician and the neurologist equipped 
with a portable color duplex ultrasound system converge at the side of the stroke patient and the patient is trans-
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The ultrasound study took place either at the site of the initial 
treatment (patient’s couch or bed) or during ambulance transport 
to the nearest stroke unit ( table 1 ). The various positioning of the 
patient in the different settings, e.g. sitting, lying, investigator in 
front or back of patient, and the sometimes bumpy ride within the 
ambulance car demanded a high experience and flexibility of the 
investigator.
 Ultrasound Equipment and Data Acquisition 
 Two portable color duplex ultrasound machines equipped 
with a phased-array transducer capable of transcranial imaging 
were used: SonoSite Micromaxx with a P17 transducer (SonoSite 
Inc., Bothell, Wash., USA) and Philips CX50 with a P2–5 trans-
ducer (Philips Ultrasound, Bothell, Wash., USA). We used the 
standard setting with a transmission frequency of 2 Hz for bright-
ness, color and Doppler mode on both machines. Images were 
stored as bitmap (Micromaxx  ) and DICOM (CX50  ) files on the 
hard drive and converted later to jpg files for data transfer and 
off-line analysis.
 Optional use of an ultrasound contrast agent (SonoVue  , 
Bracco Imaging SpA, Milan, Italy) allowed us to increase our di-
agnostic confidence in cases of inferior transcranial bone win-
dows and to save examination time  [12] ; it also proved valuable 
during examinations made difficult during emergency transport. 
Intravenous injections of 0.5–2 ml contrast agent were adminis-
tered, depending on the quality of the temporal bone window as 
previously described  [13] . After identification of the best temporal 
bone window, the protocol requested visualization in color mode 
and confirmatory flow measurements in both middle cerebral ar-
teries (MCAs) in the proximal M1 segment on both sides. After 
MCA visualization using color Doppler mode, flow measure-
ments were performed in the proximal MCA (M1) segment using 
spectral Doppler sonography. Angle correction was not per-
formed. The examiner could decide whether to extend the proto-
col to measurements in the anterior cerebral (ACA) and posterior 
cerebral (PCA) arteries. Proximal MCA occlusions were diag-
nosed when the ipsilateral ACA and/or contralateral ACA and 
MCA could be visualized, confirming the existence of a sufficient 
temporal bone window with or without echocontrast agents.  Dis-
tal MCA or MCA branch occlusions were defined according to the 
criteria published by Zanette et al.  [14] . The TCCS examination 
time was defined as the time from the first to the last image, as 
documented in the image files.
 A simplified data collection sheet was used, in which we noted 
several items: the timing of our response to the emergency call, 
arrival at the patient’s side, and beginning and end of the ultra-
sound examination; the final diagnosis after the patient’s dis-
charge from the hospital; the stroke treatment that was used; and 
whether visualization of both MCAs had been achieved. Data de-
rived from neurovascular investigations such as CT angiography 
(CTA), MR angiography (CTA), or in-house neurosonography 
were collected and correlated to the results of the prehospital 
TCCS.
 Statistical Analysis 
 Based on the data collected, we calculated the sensitivity, spec-
ificity, and positive and negative predictive values, as well as the 
respective 95% CIs, of the procedure in determining occlusion of 
the MCA. All data were entered into an Excel worksheet and cal-
culated using StatXact  9 (http://www.cytel.com).
 Results 
 During the 9-month clinical period, we used TCCS to 
examine 113 patients for acute ischemic stroke symp-
toms ( fig. 2 ). The mean time from the stroke code dis-
patch to arrival at the patient’s side was 11 min. The ex-
aminations were performed by board-certified stroke 
neurologists (S.B. examined 61 patients and F.S. 49 pa-
tients) and a senior resident with certification for neuro-
sonography by the German Society for Ultrasound in 
Medicine (M.E. examined 3 patients). The patients’ mean 
age in this study was 80.6 years (SD 13.52 years) and 56% 
of the patients were female. TCCS was performed to 
screen for major vessel occlusion in cases in which the 
symptoms were unequivocally due to stroke, as a confir-
matory investigation in cases of suspected stroke, or for 
additional exclusion in cases in which the diagnosis was 
a disease mimicking stroke or another internal medicine 
Table 1.  Study demographics
Total patients, n 113
Stayed at home (no stroke, ultrasound
examination unremarkable), n 11
Clinic admission, n 102
Mean age in years, SD 80.6813.52
Sex, w/m 63/50
Site of ultrasound examination
Patient’s home
















Time from dispatch to arrival at patient in min, SD 12.387.09
Time from arrival at patient to handover of
patient to hospital, mean 8 SD, min 53818
Ultrasound examination time, mean 8 SD, min 5.682.2
Contrast-enhanced TCCS, n 41 (36%)
Stroke1 diagnosis at hospital discharge, n 73
Intravenous thrombolysis, n
Yes 9
No due to exclusion criteria 72
Thrombectomy 1
M1–MCA occlusion, n 10 (9%)
SD = Standard deviation; S.B. = Sandra Boy; F.S. = Felix Schla-
chetzki; M.E. = Michael Ertl.
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diagnosis. As expected, 11 (10%) of 113 patients did not 
have a suitable temporal bone window; however, we did 
not administer an ultrasound contrast agent (UCA) if 
the patient’s neurological symptoms were unlikely to be 
due to stroke. The average time taken to perform TCCS 
was 5.6 min ( table 1 ). A UCA was used in 41 (36%) of 113 
cases to improve our confidence in the diagnosis or to 
save time.
 The mean time from arrival at the patient’s side to de-





n = 11 unlikely neurological case
and unremarkable TCCS exam
Excluded patients:
n = 16
n = 11 No temporal bone window
(6× one side, 5× both sides)
with 1× M2 occlusion; 1×
ICA occlusion             
n = 3 Clinical diagnosis without 
lesion in neuroimaging          
n = 1 Early lysis  







No occlusion in TCCS
n = 76
MCA-M1 occlusion S tandard stroke imaging*
occlusion no occlusion total
Preclinical TCCS occlusion 9 1** 10
no occlusion 1*** 75 76
total 10 76 86
*** CTA, MRA, and CCT according to diagnostic pathway in stroke unit.
*** Massif ICH described as distal MCA occlusion.
*** Contrast through filter; PCA described instead of MCA occlusion.
Diagnostic accuracy
Artery Se (95% CI) Sp (95% CI) PPW (95% CI) NPW (95% CI)
M1 90% (55.55–99.75) 98% (92.89–99.97) 90% (55.55–99.75) 98% (92.89–99.97)
Se = Sensitivity; Sp = specificity; PPW = positive predictive value; NPW = negative predictive value
 Fig. 2. Flow diagram showing the imaging pathway in diagnosing ischemic stroke. A 2  ! 2 table showing the calcu-
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(Department of Neurology of the University of Regens-
burg, Bezirksklinikum Regensburg, or Department of 
Neurology, Krankenhaus der Barmherzigen Brüder Re-
gensburg, Regensburg) was 53 min (SD 18 min).
 Overall, 9 of 10 MCA occlusions were correctly identi-
fied by prehospital TCCS ( fig. 3 ). In 1 patient, a PCA was 
mistaken for a patent MCA when the UCA was incor-
rectly injected through a filter system, resulting in the 
destruction of the microbubbles and inferior image qual-
ity in the early days of the study. Also, TCCS resulted in 
misdiagnosis of a distal MCA mainstem occlusion ac-
cording to the Zanette index ( fig. 4 )  [14] . In this patient, 
an atypical parietooccipital ICH caused dislocation of the 
MCA, which led to a near-perpendicular angle of in-
sonation. Retrospectively, attention to the lack of resis-
tance in the low-flow profile and the use of UCA may 
have helped to avoid the misdiagnosis. Patent MCAs, as 
demonstrated by standard neurovascular imaging (CTA, 
MRA or neurosonography) in the hospital, were diag-
nosed correctly in 75 of 76 cases. In 1 patient, in whom an 
additional atypical frontal ICH caused severe left-sided 
hemiparesis, a clinical syndrome potentially attributed to 
MCA occlusion, normal flow in the MCA was observed 
and confirmed by CTA. In 2 additional patients with 
space-occupying subdural hematomas, unremarkable 
flow was also observed in both MCAs.
 We calculated the sensitivity, specificity, positive pre-
dictive and negative predictive values in achieving a cor-
rect diagnosis of MCA occlusion. Our findings are as fol-
lows: sensitivity 90% (95% CI 55.5–99.75%); specificity 
98% (95% CI 92.89–99.97%); positive predictive value 
90% (95% CI 55.5–99.75%), and negative predictive value 
98% (95% CI 92.89–99.97%).
 Discussion 
 We were able to demonstrate that a reliable diagnosis 
of MCA occlusion can be made using a portable duplex 
ultrasound device in the prehospital setting – either at 
the site of the emergency or during patient transport. 
The added use of contrast agent microbubbles was ben-
a b
dc
 Fig. 3. Images obtained in a 57-year-old 
patient with acute left-sided hemiparesis 
and right-sided gaze.  a ,  b Contrast-en-
hanced TCCS images showing a patent left 
MCA 25 min after symptom onset ( a ) and 
proximal occlusion of the right MCA
( b ), which is consistent with the patient’s 
stroke symptoms.  c Cerebral CT scan ob-
tained 65 min after symptom onset exhib-
iting mild hypointensities of the right bas-
al ganglia.  d CTA confirming right MCA 
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eficial when there was an insufficient temporal bone 
window, to save examination time, to increase diagnostic 
confidence, or during difficult examinations. Support-
ing the clinical diagnoses of hemispheric brain ischemia 
at the earliest possible time point could potentially open 
new avenues for image-guided transcranial sonothrom-
bolysis in patients suffering acute stroke while still ‘in the 
field’.
 Ischemic stroke therapy is time critical and hence to 
decrease the time from symptom onset to initiation of 
intravenous thrombolysis, minimum diagnostic prereq-




 Fig. 4. Images obtained in an 80-year-old 
patient with acute left-sided hemiparesis 
and neglect.  a ,  b Unenhanced TCCS im-
ages obtained 30 min after symptom onset 
showing a patent left MCA and significant 
flow reduction in the right MCA, which 
was interpreted to be consistent with distal 
MCA occlusion (according to Zanette), but 
without a high-resistance flow pattern.
 c ,  d Unenhanced cerebral CT scans ob-
tained 60 min later, showing a midline 
shift at the level of the circle of Willis ( c ) 
and a large right-sided parietooccipital 
atypical ICH with a small-convexity sub-
dural hematoma ( d ).  e ,  f After intubation 
and before neurosurgical evacuation, CTA 
revealed severe dislocation of the right 
MCA, leading to a near-perpendicular an-
gle of insonation for TCCS; this was also 
reflected in the absent high-resistance 
flow pattern, which would be expected in 
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plex ultrasound systems now have image qualities high 
enough to perform neurovascular ultrasonography even 
in difficult imaging situations  [11] . Given average patient 
transport times ranging from 30 to 65 min from arrival 
at the patient’s side to patient delivery to the nearest hos-
pital, as analyzed by Teuschl and Brainin  [8]  in their re-
cent meta-analysis, prehospital TCCS may fill both a di-
agnostic and a potential therapeutic gap. A single case 
report has been published to date in which prehospital-
ization TCCS aided the clinical diagnosis of left-sided 
hemispheric stroke  [16] .
 Sonothrombolysis has emerged as a new potential tool 
for stroke therapy in combination with administration of 
rtPA or ultrasound microbubbles. Ultrasound microbub-
bles are of special interest because they could replace 
thrombolytic agents in the treatment of stroke and can be 
applied ‘in the field’. Basic mechanisms of sonothrom-
bolysis that are being investigated in this regard include, 
among others, microstreaming derived from ultrasound 
contrast agent destruction and stable cavitation  [17] . Al-
though experimental low-frequency, high-intensity ul-
trasound systems displayed greater thrombolytic poten-
tial in experimental studies, their application to human 
stroke has produced negative results, including symp-
tomatic ICH to some extent  [6, 18] . Other studies, how-
ever, in which TCD ultrasound with and without contrast 
agents provided faster relief of an intra-arterial clot bur-
den, leading to faster recanalization in experimental and 
clinical studies  [5, 7, 10, 19, 20] .
 Symptomatic ICH is a serious differential diagnosis 
for ischemic stroke. In this study, we only had 2 cases of 
ICH. Both ICHs were not visualized because prehospital 
TCCS was not performed to exclude hemorrhage but to 
primarily detect a major MCA occlusion. In one of these 
cases, displacement of the MCA led to a false diagnosis 
of distal MCA occlusion. This misdiagnosis could have 
been avoided if we had taken into account the Zanette 
index as well as the missing high-resistance flow pattern 
associated with distal occlusion. The other patient, a 
case of atypical frontal ICH, had an unremarkable flow 
profile in the MCA . The only scenario in which ICH 
would lead to MCA occlusion would be a massive space-
occupying hemorrhage along with a high Glasgow Coma 
Scale score. In other words, MCA occlusions are a high-
ly unexpected finding in patients suffering from typical 
hypertensive basal ganglia ICHs. Two additional pa-
tients had symptomatic space-occupying subdural he-
matomas, which caused stroke-like symptoms, and an 
unremarkable MCA flow. Overall, the incidence of ICH 
was lower than expected in our study compared with 
general statistics, i.e. those published in the Interstroke 
Study  [21] .
 Little is known about the effect of contrast-enhanced 
TCCS on the ICH itself. To date, diagnostic ce-TCCS has 
been extremely safe, and there have been no published 
reports of related ICH or related blood-brain barrier 
opening in rabbits and humans, which represents a lesser 
form of neurovascular compromise  [22–24] . Although 
some risk may exist, ultrasound spatial peak–temporal 
peak intensities, as well as rarefactional pressure values, 
are significantly attenuated by the temporal bone, and the 
mechanical effects of the microbubble response are lim-
ited to the intravascular compartment. Stroick et al.  [25] 
 performed a study using a rat model of ICH in which they 
injected collagenase intracerebrally to produce a basal 
ganglia hemorrhage. This elegant study in which ce-
TCCS was performed with a 50-mm spacer between 
transducer and skull to account for differences in the 
beam did not lead to greater hemorrhage volumes, edema 
or clinical deterioration in rats.
 The ‘stroke mobile’ concept applied in this study did 
not lead to any delay in prehospital management after 
the patient’s arrival until handover in the hospital (mean 
time 65  8 25 min) since the neurological and ultrasound 
investigation was performed either during transport or 
before the stretcher arrived. Duration of patient trans-
port was comparable to previously published data  [8, 26] . 
Half of the TCCS examinations were performed at the 
primary site of the stroke incident and most were fin-
ished before the first-aid personnel arrived with the 
stretcher. We performed 49 (43%) of the 113 investiga-
tions during transport in the ambulance; these cases 
were sometimes challenging and often led to administra-
tion of UCA for diagnostic confidence and reduced time. 
Other strategies of prehospital stroke imaging and treat-
ment include the use of mobile CT scanners with tele-
medicine support, presence of a neurologist, technicians, 
and access to clinical chemistry, which are all represent-
ed in the ‘Mobile Stroke Unit’, available in Homburg 
since 2008, and the ‘STEMO – Stroke Emergency Mo-
bile’, available in Berlin since 2011  [27] . The only 2 cases 
published so far had a dispatch-to-decision time of 35 
min, which is shorter than the average dispatch-to-nee-
dle time in conventional stroke unit scenarios. Prehospi-
tal neurosonography in cases of proven MCA occlusion 
with corresponding neurological symptoms as shown in 
 figure 2 may become more frequent with increasing ex-
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 In summary, this first large study on prehospital neu-
rosonography with neurological expertise in acute stroke 
therapy demonstrates the high sensitivity and specificity 
of TCCS examinations ‘in the field’ in detecting throm-
botic conditions – mainly MCA occlusions. The ultra-
sound investigation should be performed by a well-
trained and experienced investigator and interpreted 
only in the context of the neurological symptoms. This 
study forms the basis on which further refinements and 
standardizations of prehospital neurosonography and 
neurological stroke assessment can be made. Ultimately, 
patient transport to the nearest stroke unit provides a rel-
evant time window for sonothrombolyis in acute MCA 
occlusion.
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